In this regard, a seminal paper investigating targeting the tumour endothelial marker and immunomodulatory molecule CD276 (also referred to as B7‐H3) described that the most important determining factor for avoiding toxicity is in fact level of expression 222, 223. This evidence concerns the gene CD276 and neoplasm.